Browsing by Author YAP CHUN WEI

Select a letter below to browse by last name or type
0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z


Showing results 53 to 63 of 63 < previous 
Issue DateTitleAuthor(s)
19-Nov-2012Rational design of selective organoruthenium inhibitors of protein tyrosine phosphatase 1BOng, J.X.; Yap, C.W. ; Ang, W.H. 
Nov-2007Regression methods for developing QSAR and QSPR models to predict compounds of specific pharmacodynamic, pharmacokinetic and toxicological propertiesYap, C.W. ; Li, H. ; Ji, Z.L.; Chen, Y.Z. 
Nov-2007Regression methods for developing QSAR and QSPR models to predict compounds of specific pharmacodynamic, pharmacokinetic and toxicological propertiesYap, C.W. ; Li, H. ; Ji, Z.L.; Chen, Y.Z. 
Jun-2012Selective agonism of human pregnane X receptor by individual ginkgolidesLau, A.J.; Yang, G.; Yap, C.W. ; Chang, T.K.H.
Oct-2010Solubilization of vorinostat by cyclodextrinsCai, Y.Y.; Yap, C.W. ; Wang, Z.; Ho, P.C. ; Chan, S.Y. ; Ng, K.Y. ; Ge, Z.G.; Lin, H.S. 
Dec-2005Statistical learning approach for predicting specific pharmacodynamic, pharmacokinetic, or toxicological properties of pharmaceutical agentsLi, H. ; Yap, C.W. ; Xue, Y.; Li, Z.R.; Ung, C.Y. ; Han, L.Y. ; Chen, Y.Z. 
Jun-2010Surface tension and wettability in transdermal delivery: A study on the in-vitro permeation of haloperidol with cyclodextrin across human epidermisAzarbayjani, A.F.; Lin, H. ; Yap, C.W. ; Chan, Y.W.; Chan, S.Y. 
27-Apr-2009SVM model for virtual screening of Lck inhibitorsLiew, C.Y.; Ma, X.H. ; Liu, X.; Yap, C.W. 
Jun-2006Therapeutic targets: Progress of their exploration and investigation of their characteristicsZheng, C.J. ; Han, L.Y. ; Yap, C.W. ; Ji, Z.L. ; Cao, Z.W. ; Chen, Y.Z. 
Mar-2005Trends in exploration of therapeutic targetsZheng, C.J. ; Han, L.Y. ; Yap, C.W. ; Xie, B.; Chen, Y.Z. 
22-Sep-2004TRMP: A database of therapeutically relevant multiple pathwaysZheng, C.J. ; Zhou, H.; Xie, B.; Han, L.Y. ; Yap, C.W. ; Chen, Y.Z.